Purpose-built for every stakeholder
Explore how Clincove transforms operations for your organization.
Small Biopharma
Institutional-grade infrastructure without the enterprise price tag
Large Pharma & CROs
Real-time trial oversight with zero reconciliation delays
Research Clinics
Launch your research site without hiring an army of admins
Centralized document management with powerful viewer
View, annotate, and manage all your clinical trial documents in one place. Our built-in document viewer supports PDFs, version control, assignment tracking, and real-time collaboration between sites and sponsors.
- Built-in PDF viewer with search, rotate, and zoom
- Version control and document history tracking
- Assign documents to team members with deadlines
- Real-time sync between site and sponsor eTMF
Source Data Verification
Keyboard ShortcutsSource Documents
Modern data capture with built-in source verification
Capture, verify, and monitor clinical data with our next-generation EDC. Side-by-side source document viewing eliminates tab-switching. Real-time status tracking keeps your entire team aligned across every visit.
- Side-by-side source document verification
- Visit-based form navigation with live status indicators
- Integrated PDF viewer for source medical records
- Keyboard shortcuts and minimap for efficient review
Navigate protocols with your AI expert
Ask questions about any clinical trial protocol and get instant, reliable answers. Protocol AI reads your full document and surfaces inclusion criteria, endpoints, safety reporting, and more — so your team spends less time searching and more time executing.
- Natural language questions over your full protocol
- Instant answers on eligibility, endpoints, and safety
- Side-by-side PDF viewer with AI-powered chat
- Reduce protocol training time for site teams
Protocol Title: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Neravex (CLT-105) in Adults with Generalized Anxiety Disorder (GAD)
Clarion Therapeutics
123 Road St East
Toronto, Ontario, Canada
A1A 1A1
Medical Advisor
Sousa, Michael
Tel: +1-416-555-5555
Section 5.2
EXCLUSION CRITERIA
Subjects meeting any of the following criteria will be excluded from participation in this study:
Your AI Protocol Expert
Welcome to the Protocol AI — your interactive guide to navigating your trial protocol. Ask questions and uncover insights quickly.
Based on Section 5.2 of the protocol, the key exclusion criteria are:
- Current diagnosis of Major Depressive Disorder (MDD)
- History of bipolar, schizophrenia, or psychotic disorders
- Active suicidal ideation (C-SSRS score ≥ 4)
- Known hypersensitivity to CLT-105
- Use of prohibited medications (MAOIs, benzodiazepines) within 14 days
Referenced from page 8, Section 5.2
Everything talks to everything.
A true ecosystem, not a Frankenstein stack.
eISF & eTMF Sync
What happens at the site instantly reflects at the sponsor level. Total visibility, zero email attachments.
Protocol AI
Ingest protocols instantly to auto-generate forms, visits, and budgets.
Modern EDC
Say goodbye to double data entry with seamless eSource to EDC data flow.
Ready to de-risk your next trial?
Join leading biopharmas, global pharmas, and research clinics who have unified their clinical operations. Deploy in weeks, not months.